Boaz Shaer

484 citations
7 papers · 384 indexed · h-index 6
Topics
Ocular Diseases and Behçet’s Syndrome (6 papers)Retinal and Optic Conditions (2 papers)SARS-CoV-2 and COVID-19 Research (2 papers)

In The Last Decade

Boaz Shaer

7 papers receiving 374 citations

Peers

Boaz Shaer
Comparison fields: 5 of 34
  • Ophthalmology 360
  • Infectious Diseases 74
  • Pulmonary and Respiratory Medicine 69
  • Rheumatology 69
  • Immunology 30
Replace Sofia Tognon with:
Sofia Tognon Italy
Leila Kump United States
Sukhum Silpa‐archa Thailand
Georgina Maalouf France
Samendra Karkhur India
Chantal Adani Italy
Paola Pivetti Pezzi Italy
Gülten Sungur Türkiye
Mert Şimşek Türkiye
R. Crouch Australia
Boaz Shaer relative to Sofia Tognon Italy Sofia Tognon's profile →
Citations per field
00.5×5.9×
Sofia Tognon · 1×
Citations per year

Countries citing papers authored by Boaz Shaer

Since Specialization
Citations

This map shows the geographic impact of Boaz Shaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boaz Shaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boaz Shaer more than expected).

Fields of papers citing papers by Boaz Shaer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boaz Shaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boaz Shaer. The network helps show where Boaz Shaer may publish in the future.

Co-authorship network of co-authors of Boaz Shaer

This figure shows the co-authorship network connecting the top 25 collaborators of Boaz Shaer. A scholar is included among the top collaborators of Boaz Shaer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boaz Shaer. Boaz Shaer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 56
2 85
3 79
4 49
5
Increased CD4+ expression and decreased IL-10 in the anterior chamber in idiopathic uveitis.
53
6 60
7
[Excimer laser photorefractive keratectomy for myopia].
2

About Boaz Shaer

Boaz Shaer is a scholar working on Ophthalmology, Rheumatology and Infectious Diseases, having authored 7 papers that have together received 384 indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (6 papers), Retinal and Optic Conditions (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Ophthalmology (360 citations), Rheumatology (69 citations) and Infectious Diseases (74 citations). Boaz Shaer has collaborated with scholars based in United Kingdom, Israel and Australia. Frequent co-authors include H M A Towler, Peter McCluskey, Virginia L. Calder, Susan Lightman, Yael Ben‐Arie‐Weintrob, Hadas Newman, Shiri Shulman, Zohar Habot‐Wilner, Naomi Fischer and Vicktoria Vishnevskia‐Dai. Their work appears in journals such as Ophthalmology, Clinical & Experimental Immunology and Retina.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026